Imaging in Interventional Radiology: Applications of Contrast-Enhanced Ultrasound

Abstract

This review explores the applications of contrast-enhanced ultrasound (CEUS) in interventional radiology, focusing on its role in endoleak detection after endovascular abdominal aortic aneurysm repair (EVAR), periprocedural thermal ablation guidance, and transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). CEUS offers a dynamic assessment for the detection of endoleak following EVAR, facilitating accurate diagnosis and classification. In periprocedural thermal ablation, CEUS enhances target lesion delineation with the visualization of real-time perfusion changes, optimizing treatment strategies and reducing residual tumor rates. Finally, CEUS has demonstrated efficacy in intraprocedural evaluation and postprocedural follow-up in TACE for HCC, offering early detection of residual tumor enhancement and providing an alternative for patients with contraindications to contrast-enhanced computed tomography or magnetic resonance imaging. Overall, CEUS is a versatile and valuable tool with many applications to offer interventional radiologists enhanced diagnostic capabilities and improved patient management.

Keywords

contrast-enhanced ultrasound - endoleak - thermal ablation - transarterial chemoembolization - interventional radiology

Publikationsverlauf

Artikel online veröffentlicht:
19. August 2024

• References

• 1 American College of Radiology Committee on LI-RADS® (Liver). CEUS LI-RADS v2017 CORE. Accessed March 1, 2024 at: https://www.acr.org/-/media/ACR/Files/RADS/LI-RADS/CEUS-LI-RADS-2017-Core.pdf
• 2 Hyvelin JM, Gaud E, Costa M. et al. Characteristics and echogenicity of clinical ultrasound contrast agents: an in vitro and in vivo comparison study. J Ultrasound Med 2017; 36 (05) 941-953
• 3 Giles KA, Pomposelli F, Hamdan A, Wyers M, Jhaveri A, Schermerhorn ML. Decrease in total aneurysm-related deaths in the era of endovascular aneurysm repair. J Vasc Surg 2009; 49 (03) 543-550 , discussion 550–551
• 4 Buth J, Harris PL, van Marrewijk C, Fransen G. The significance and management of different types of endoleaks. Semin Vasc Surg 2003; 16 (02) 95-102
• 5 Lal BK, Zhou W, Li Z. et al; OVER Veterans Affairs Cooperative Study Group. Predictors and outcomes of endoleaks in the Veterans Affairs Open Versus Endovascular Repair (OVER) trial of abdominal aortic aneurysms. J Vasc Surg 2015; 62 (06) 1394-1404
• 6 White HA, Macdonald S. Estimating risk associated with radiation exposure during follow-up after endovascular aortic repair (EVAR). J Cardiovasc Surg (Torino) 2010; 51 (01) 95-104
• 7 Guo Q, Zhao J, Huang B. et al. A systematic review of ultrasound or magnetic resonance imaging compared with computed tomography for endoleak detection and aneurysm diameter measurement after endovascular aneurysm repair. J Endovasc Ther 2016; 23 (06) 936-943
• 8 Jung EM, Rennert J, Fellner C. et al. Detection and characterization of endoleaks following endovascular treatment of abdominal aortic aneurysms using contrast harmonic imaging (CHI) with quantitative perfusion analysis (TIC) compared to CT angiography (CTA). Ultraschall Med 2010; 31 (06) 564-570
• 9 Clevert DA, Horng A, Clevert DA, Jung EM, Sommer WH, Reiser M. Contrast-enhanced ultrasound versus conventional ultrasound and MS-CT in the diagnosis of abdominal aortic dissection. Clin Hemorheol Microcirc 2009; 43 (1-2): 129-139
• 10 Gummadi S, Eisenbrey JR, Lyshchik A. A narrative review on contrast-enhanced ultrasound in aortic endograft endoleak surveillance. Ultrasound Q 2018; 34 (03) 170-175
• 11 Madsen HHT, Rasmussen F. Contrast-enhanced ultrasound in oncology. Cancer Imaging 2011; 11 Spec No A (1A): S167-S173
• 12 Huang DY, Yusuf GT, Daneshi M. et al. Contrast-enhanced US-guided interventions: improving success rate and avoiding complications using US contrast agents. Radiographics 2017; 37 (02) 652-664
• 13 Mauri G, Porazzi E, Cova L. et al. Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment. Insights Imaging 2014; 5 (02) 209-216
• 14 Zhao X, Wang W, Zhang S. et al. Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: a retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients. Abdom Imaging 2012; 37 (05) 885-891
• 15 Minami Y, Kudo M, Kawasaki T, Chung H, Ogawa C, Shiozaki H. Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography. AJR Am J Roentgenol 2004; 183 (01) 153-156
• 16 Altekruse SF, Henley SJ, Cucinelli JE, McGlynn KA. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Am J Gastroenterol 2014; 109 (04) 542-553
• 17 Shiozawa K, Watanabe M, Ikehara T. et al. Efficacy of intra-arterial contrast-enhanced ultrasonography during transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma. World J Hepatol 2018; 10 (01) 95-104
• 18 Brown DB, Nikolic B, Covey AM. et al; Society of Interventional Radiology Standards of Practice Committee. Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol 2012; 23 (03) 287-294
• 19 Kono Y, Lucidarme O, Choi SH. et al. Contrast-enhanced ultrasound as a predictor of treatment efficacy within 2 weeks after transarterial chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 2007; 18 (1, Pt 1): 57-65
• 20 Shaw CM, Eisenbrey JR, Lyshchik A. et al. Contrast-enhanced ultrasound evaluation of residual blood flow to hepatocellular carcinoma after treatment with transarterial chemoembolization using drug-eluting beads: a prospective study. J Ultrasound Med 2015; 34 (05) 859-867